PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial used an ethnodrama — basically a theatrical performance — to address PrEP stigma among women; can you explain how that kind of community-based approach might compare to a one-on-one conversation with you about starting PrEP?
2. 2Since this was a pilot study focused on whether the drama intervention could even be carried out feasibly — like how many shows were performed and how many women attended — rather than on measuring whether it actually changed PrEP use or reduced stigma, what do you think the next steps in this research would need to show before it could meaningfully inform my care?
3. 3The trial specifically looked at PrEP stigma as a barrier for women living with HIV risk — is stigma or social pressure something you think might be affecting my own comfort or willingness to consider PrEP, and how do you address that in your practice?
4. 4Because this study is already completed and only measured feasibility, not clinical outcomes like HIV prevention rates, is there other completed research on PrEP access and stigma in women that you'd recommend I look at alongside this?
5. 5Given that this trial targeted women as a specific group, are there particular considerations around PrEP for women — like side effects, dosing, or insurance coverage — that you think I should understand before deciding whether PrEP is worth discussing further for my situation?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.